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NMR analysis Figure S1 : 1 H-NMR spectrum of HPFO (600 ppm) in PFO recorded using coaxial tube. Table 2 for both cell lines.
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In this work, the ERETIC2 methodology that correlates the absolute intensities in two 1D-NMR spectra via the principle of reciprocity, 1 implemented in the Bruker TopSpin software, 2 was used to quantify the protonated impurity in commercially available PFCLs.
The quantitation of two partially hydrogenated PFO analogs, HPFO and 5HPFO, dissolved in PFO was performed using a coaxial tube owing to the immiscibility of perfluoroalkyl compounds in conventional deuterated solvents. The analyte solution was placed in the 3-mm insert tube, whereas deuterated lock solvent (CDCl 3 ) in the external section. Acquired NMR spectra were the sums of 1700 transients. The receiver gain (RG) was set automatically by the rga command on the high-concentration sample to avoid the analog-digital converter (ADC) overflow, and the determined value (203) was used in all the successive NMR experiments.
The two analytes-HPFO and 5HPFO-were alternatively quantified using TCMB as an external standard 3 . The analyte solution was placed in the 3-mm insert tube, while the standard solution in CDCl 3 was placed in the external section of a coaxial NMR tube. This assembly prevents the analyte and reference materials from mixing and occurring as a homogeneous solution; in other words, these materials do not occupy the same volume. Thus, the concentration of analytes in the insert-tube assembly cannot be calculated from that of the reference substance because it requires the reference and analyte substances to exist as homogeneous liquids. 4 This was circumvented by determining a correction factor for the coaxial tube that considers the volume occupied by both the analyte and reference material. 4 The correction factor, for the use of coaxial S4 NMR tube, was determined using a 300-ppm HPFO reference solution and it was successively used for all the high-precision coaxial NMR tubes obtained from the same supplier.
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Figure S6
Correlation between H-content and cytotoxicity of PFO solutions according to concentrations reported in Table 2 
